Method of treating erythropoietin hyporesponsive anemias

Details Method of treating erythropoietin hyporesponsive anemias Method of treating erythropoietin hyporesponsive anemias

A - Human Necessities

61

K

A61K 38/16 (2006.01) A61P 7/06 (2006.01) A61K 38/18 (2006.01)

Patent

CA 2710253

The invention relates to methods of using compositions comprising EPO-mimetic peptides to treat anemia. The invention relates to methods of treating disorders characterized by the insufficient amounts of erythrocytes and hemoglobulin in the blood due to myelodysplastic syndrome (MDS) or by hemoglobinopathies, such as alpha- or beta-thalessemia or sickle cell disease.

L'invention porte sur des procédés d'utilisation de compositions comprenant des peptides mimétiques de l'EPO pour traiter une anémie. L'invention porte sur des procédés de traitement de troubles caractérisés par les quantités insuffisantes d'érythrocytes et d'hémoglobuline dans le sang en raison d'un syndrome myélodysplasique (MDS) ou par des hémoglobinopathies, telles qu'une alpha ou bêta-thalassémie ou une drépanocytose.

Affiliated with

Also associated with

Rating

Method of treating erythropoietin hyporesponsive anemias does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating erythropoietin hyporesponsive anemias, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating erythropoietin hyporesponsive anemias will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1420216